Comparative Efficacy and Safety of Drug-Eluting Stent and Conventional Therapies in Coronary Heart Disease Patients with In-Stent Restenosis: A Meta-Analysis
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cell Biology,Biochemistry,General Medicine,Biophysics
Link
http://link.springer.com/content/pdf/10.1007/s12013-013-9692-7.pdf
Reference43 articles.
1. Liistro, F., Fineschi, M., Angioli, P., et al. (2006). Effectiveness and safety of sirolimus stent implantation for coronary in-stent restenosis: The TRUE (Tuscany registry of sirolimus for unselected in-stent restenosis) registry. Journal of the American College of Cardiology, 48, 270–275.
2. Aminian, A., Kabir, T., & Eeckhout, E. (2009). Treatment of drug-eluting stent restenosis: An emerging challenge. Catheterization and Cardiovascular Interventions, 74, 108–116.
3. Wijns, W., Kolh, P., Danchin, N., et al. (2010). Guidelines on myocardial revascularization. European Heart Journal, 31, 2501–2555.
4. Neumann, F. J., Desmet, W., Grube, E., et al. (2005). Effectiveness and safety of sirolimus-eluting stents in the treatment of restenosis after coronary stent placement. Circulation, 111, 2107–2111.
5. Kastrati, A., Mehilli, J., von Beckerath, N., et al. (2005). Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: A randomized controlled trial. JAMA, 293, 165–171.
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Prevention of in-stent restenosis with endothelial progenitor cell (EPC) capture stent placement combined with regional EPC transplantation: An atherosclerotic rabbit model;Cardiology Journal;2019-06-27
2. Drug-eluting balloons versus new generation drug-eluting stents for the management of in-stent restenosis: an updated meta-analysis of randomized studies;J GERIATR CARDIOL;2019
3. Comparison of the Efficacy of Paclitaxel-Eluting Balloon Catheters and Everolimus-Eluting Stents in the Treatment of Coronary In-Stent Restenosis;Circulation: Cardiovascular Interventions;2016-04
4. Design of clinical intelligent percutaneous myocardial laser revascularization operating platform software;MATEC Web of Conferences;2016
5. Characteristics and trends of POBA in current DES Era;CARDIOVASC INTERV TH;2015
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3